Coronary Disease/Myocardial Infarction
RSSArticles
-
Colchicine for Recurrent Pericarditis
Although colchicine has been shown to be effective for the treatment of acute pericarditis and first recurrences, little information exists about its use in patients with multiple recurrences. Thus, Imazio et al reported on the results of the colchicine for recurrent pericarditis 2 (CORP-2) trial. -
Bioabsorbable Coronary Scaffolds: Promise and Peril
Clinical outcomes from percutaneous coronary intervention (PCI) have steadily improved over time, with transitions from balloon angioplasty to bare-metal stenting, and more recently from first-generation drug-eluting stents (DES) to second- and third-generation designs. -
Is Left Atrial Appendage Occlusion with the Watchman Device a Reasonable Alternative to Anticoagulation with Warfarin?
The goal of the Watchman LAA Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy (PREVAIL) trial was to assess the safety and efficacy of left atrial appendage (LAA) occlusion for stroke prevention in patients with atrial fibrillation (AF) compared with long-term warfarin therapy -
Is Less More? Transfemoral TAVR: The Minimalist Approach
Since its initial FDA approval in November 2011, transcatheter aortic valve replacement (TAVR) has rapidly gained acceptance as a standard therapy in the United States. -
Predicting Sudden Death Risk in Hypertrophic Cardiomyopathy
-
Renin-angiotensin System Antagonists in Stable CAD
-
Prehospital Ticagrelor Administration in STEMI Patients Falls Short
-
Is There a Role for Routine Procainamide Infusion in the Evaluation of Patients with Cardiac Arrest?
-
Peri-procedural Management of New Oral Anticoagulants
-
FFR in Stable Coronary Artery Disease: A Second Chance at FAME?